‘Rhoda’ Actress’s Cancer Miracle

Valerie Harper Image by getty images
Actress Valerie Harper’s brain cancer is nearing remission, her physician said in an excerpt of a documentary that was shown on NBC’s “Today” show.
“I’d say that we’re getting pretty close to remission,” neuro-oncologist Dr. Jeremy Rudnick said in a documentary that will air next month on the U.S. network.
“It defies the odds,” he added, as Harper sat listening to the results of tests conducted in June.
Harper, 74, won four Emmy Awards for her signature role of Rhoda Morgenstern on the hit 1970s sitcoms “The Mary Tyler Moore Show” and spin-off “Rhoda.” The actress said in March that her diagnosis of leptomeningeal carcinomatosis – cancer in the membrane of her brain – meant she had as little as three months to live.
In June, NBC announced that it was shooting a documentary about Harper and her treatment.
Rudnick cautioned in the segment that resistance to treatment is all-but-assured, saying, “it’s not a matter of if, but of when.” The actress has received treatment ranging from chemotherapy to acupuncture.
“I am afraid of what’s ahead,” Harper said. “But, so what? There’s much to be afraid of in life.”
Harper completed a tour promoting her new autobiography “I, Rhoda” shortly before going public with her illness. Last year she starred on Broadway as actress Tallulah Bankhead in “Looped,” for which she earned a Tony nomination.
Harper has continued to work since her diagnosis, notably in an upcoming episode of the cable comedy series “Hot in Cleveland” in which she guest-starred with former cast mates Mary Tyler Moore, Cloris Leachman and series regular Betty White.
The Forward is free to read, but it isn’t free to produce

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward.
Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.
At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse.
This is a great time to support independent Jewish journalism you rely on. Make a Passover gift today!
— Rachel Fishman Feddersen, Publisher and CEO
Most Popular
- 1
News Student protesters being deported are not ‘martyrs and heroes,’ says former antisemitism envoy
- 2
News Who is Alan Garber, the Jewish Harvard president who stood up to Trump over antisemitism?
- 3
Fast Forward Suspected arsonist intended to beat Gov. Josh Shapiro with a sledgehammer, investigators say
- 4
Politics Meet America’s potential first Jewish second family: Josh Shapiro, Lori, and their 4 kids
In Case You Missed It
-
Opinion Why can Harvard stand up to Trump? Because it didn’t give in to pro-Palestinian student protests
-
Culture How an Israeli dance company shaped a Catholic school boy’s life
-
Fast Forward Brooklyn event with Itamar Ben-Gvir cancelled days before Israeli far-right minister’s US trip
-
Culture How Abraham Lincoln in a kippah wound up making a $250,000 deal on ‘Shark Tank’
-
Shop the Forward Store
100% of profits support our journalism
Republish This Story
Please read before republishing
We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:
- Credit the Forward
- Retain our pixel
- Preserve our canonical link in Google search
- Add a noindex tag in Google search
See our full guidelines for more information, and this guide for detail about canonical URLs.
To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.